Depreciation of NantHealth, Inc. from 31 Dec 2014 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NantHealth, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 30 Sep 2023.
  • NantHealth, Inc. Depreciation for the quarter ending 30 Sep 2023 was $3,820,000, a 136% increase year-over-year.
  • NantHealth, Inc. Depreciation for the twelve months ending 30 Sep 2023 was $9,046,000, a 43% increase year-over-year.
  • NantHealth, Inc. annual Depreciation for 2022 was $6,513,000, a 9.8% increase from 2021.
  • NantHealth, Inc. annual Depreciation for 2021 was $5,932,000, a 20% decline from 2020.
  • NantHealth, Inc. annual Depreciation for 2020 was $7,394,000, a 40% decline from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

NantHealth, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $9,046,000 $3,820,000 +$2,200,000 +136% 01 Jul 2023 30 Sep 2023 10-Q 22 Nov 2023 2023 Q3
Q2 2023 $6,846,000 $1,790,000 +$231,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 22 Aug 2023 2023 Q2
Q1 2023 $6,615,000 $1,739,000 +$102,000 +6.2% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $6,513,000 $1,697,000 +$195,000 +13% 01 Oct 2022 31 Dec 2022 10-K 14 Apr 2023 2022 Q4
Q3 2022 $6,318,000 $1,620,000 +$116,000 +7.7% 01 Jul 2022 30 Sep 2022 10-Q 22 Nov 2023 2023 Q3
Q2 2022 $6,202,000 $1,559,000 +$44,000 +2.9% 01 Apr 2022 30 Jun 2022 10-Q 22 Aug 2023 2023 Q2
Q1 2022 $6,158,000 $1,637,000 +$226,000 +16% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $5,932,000 $1,502,000 -$200,000 -12% 01 Oct 2021 31 Dec 2021 10-K 14 Apr 2023 2022 Q4
Q3 2021 $6,132,000 $1,504,000 -$381,000 -20% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $6,513,000 $1,515,000 -$284,000 -16% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $6,797,000 $1,411,000 -$597,000 -30% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $7,394,000 $1,702,000 -$620,000 -27% 01 Oct 2020 31 Dec 2020 10-K 25 Feb 2022 2021 Q4
Q3 2020 $8,014,000 $1,885,000 -$1,219,000 -39% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $9,233,000 $1,799,000 -$1,787,000 -50% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $11,020,000 $2,008,000 -$1,256,000 -38% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q4 2019 $12,276,000 $2,322,000 -$1,014,000 -30% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021 2020 Q4
Q3 2019 $13,290,000 $3,104,000 -$96,000 -3% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $13,386,000 $3,586,000 +$549,000 +18% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $12,837,000 $3,264,000 +$194,000 +6.3% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $12,643,000 $3,336,000 +$766,000 +30% 01 Oct 2018 31 Dec 2018 10-K 28 Feb 2020 2019 Q4
Q3 2018 $11,877,000 $3,200,000 +$3,000 +0.09% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019 2019 Q3
Q2 2018 $11,874,000 $3,037,000 -$448,000 -13% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $12,322,000 $3,070,000 -$41,000 -1.3% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $12,363,000 $2,570,000 +$146,000 +6% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 Q4
Q3 2017 $12,217,000 $3,197,000 +$1,202,000 +60% 01 Jul 2017 30 Sep 2017 10-Q 21 Nov 2018 2018 Q3
Q2 2017 $11,015,000 $3,485,000 +$1,529,000 +78% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $9,486,000 $3,111,000 +$1,398,000 +82% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $8,088,000 $2,424,000 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018 2017 Q4
Q3 2016 $1,995,000 +$1,019,000 +104% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $1,956,000 +$1,103,000 +129% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $1,713,000 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q3 2015 $976,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $853,000 01 Apr 2015 30 Jun 2015 10-Q/A 14 Sep 2016 2016 Q2

NantHealth, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $6,513,000 +$581,000 +9.8% 01 Jan 2022 31 Dec 2022 10-K 14 Apr 2023 2022 FY
2021 $5,932,000 -$1,462,000 -20% 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023 2022 FY
2020 $7,394,000 -$4,882,000 -40% 01 Jan 2020 31 Dec 2020 10-K 25 Feb 2022 2021 FY
2019 $12,276,000 -$367,000 -2.9% 01 Jan 2019 31 Dec 2019 10-K 26 Feb 2021 2020 FY
2018 $12,643,000 +$280,000 +2.3% 01 Jan 2018 31 Dec 2018 10-K 28 Feb 2020 2019 FY
2017 $12,363,000 +$4,275,000 +53% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $8,088,000 +$4,427,000 +121% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
2015 $3,661,000 +$2,210,000 +152% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2014 $1,451,000 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.